Supplementary
. Effect of high fat diet feeding on body weight and glucose tolerance in C57BL6 mice.A. Body weight and B. glucose tolerance test (GTT) of C57BL6 mice after 12 wks of HFD feeding before oxfenicine treatment. Values represent mean ± SEM (n = 6-9). Differences were determined using a 2-way ANOVA followed by a Bonferroni post-hoc analysis. *P<0.05, significantly different from the low fat diet mice. Supplementary Figure 2 . Treatment of HFD fed mice with oxfenicine results in inhibition of carnitine palmitoyltransferase 1 (CPT-1) activity in gastrocnemius muscles. Malonyl CoA levels in gastrocnemius muscles of HFD fed C57BL6 mice after treatment with vehicle or oxfenicine. Values represent mean ± SEM (n = 6-9). Differences were determined using 2 -tailed Student's t test. *P<0.05, significantly different from the low fat diet mice. Mice were given a LF or HF diet for 12 wks after which HFD fed C57BL6 mice were treated with oxfenicine during the 4 wk period at 150mg/kg/day. Tests were performed during the 4 wk treatment period as depicted in the figure.
Supplementary Figure 2.

Supplementary
Supplementary Figure 5 . Effect of oxfenicine treatment on glycogen metabolism in gastrocnemius muscles A. Glycogen content in gastrocnemius muscles of HFD fed C57BL6 mice given vehicle or oxfenicine treatment. B. Phosphorylation status of GSK in gastrocnemius muscles of HFD fed C57BL6 mice after treatment with vehicle or oxfenicine.
